Fundz
Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Transgene and ProBioGen Enter License Agreement for Individualized Cancer Vaccine Development

Nov 05, 2024•almost 2 years ago

Contract Type

partnership

Bas-RhinBiotechnologyHealth CareTherapeutics

Description

Transgene and ProBioGen have entered into a partnership to advance individualized cancer vaccine development. The collaboration aims to combine ProBioGen's specific production technology with Transgene's individualized cancer vaccine program and its myvac® platform.

Company Information

Company

Transgene

Location

Bas-Rhin, Grand Est, France

About

Transgene is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses with the goal of indirectly or directly killing cancer cells.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Transgene's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.